JOLINDA_MEDICAL_SUPPLIES_ - Accounts


Company registration number 03691473 (England and Wales)
JOLINDA MEDICAL SUPPLIES LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023
PAGES FOR FILING WITH REGISTRAR
JOLINDA MEDICAL SUPPLIES LTD
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 5
JOLINDA MEDICAL SUPPLIES LTD
BALANCE SHEET
AS AT 31 MARCH 2023
31 March 2023
- 1 -
2023
2022
Notes
£
£
£
£
Fixed assets
Tangible assets
3
696
1,867
Current assets
Stocks
96,778
55,618
Debtors
4
308,242
273,555
Cash at bank and in hand
310,512
260,250
715,532
589,423
Creditors: amounts falling due within one year
5
(76,183)
(46,188)
Net current assets
639,349
543,235
Total assets less current liabilities
640,045
545,102
Provisions for liabilities
(115)
(334)
Net assets
639,930
544,768
Capital and reserves
Called up share capital
1,098
1,098
Profit and loss reserves
638,832
543,670
Total equity
639,930
544,768

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 March 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

JOLINDA MEDICAL SUPPLIES LTD
BALANCE SHEET (CONTINUED)
AS AT 31 MARCH 2023
31 March 2023
- 2 -
The financial statements were approved by the board of directors and authorised for issue on 30 October 2023 and are signed on its behalf by:
Mr Barry Mickler
Mrs Melanie Mickler
Director
Director
Company Registration No. 03691473
JOLINDA MEDICAL SUPPLIES LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023
- 3 -
1
Accounting policies
Company information

Jolinda Medical Supplies Ltd is a private company limited by shares incorporated in England and Wales. The registered office is 3a Chestnut House, Farm Close, Shenley, Hertfordshire, United Kingdom, WD7 9AD.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Fixtures and fittings
25% on cost

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell, after making allowance for obsolete and slow moving stock.

1.5
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

JOLINDA MEDICAL SUPPLIES LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2023
1
Accounting policies
(Continued)
- 4 -
Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.6
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.7
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2023
2022
Number
Number
Total
2
2
JOLINDA MEDICAL SUPPLIES LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2023
- 5 -
3
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 April 2022 and 31 March 2023
11,177
Depreciation and impairment
At 1 April 2022
9,310
Depreciation charged in the year
1,171
At 31 March 2023
10,481
Carrying amount
At 31 March 2023
696
At 31 March 2022
1,867
4
Debtors
2023
2022
Amounts falling due within one year:
£
£
Trade debtors
75,280
33,541
Corporation tax recoverable
-
0
8,654
Other debtors
232,962
231,360
308,242
273,555
5
Creditors: amounts falling due within one year
2023
2022
£
£
Trade creditors
37,790
27,899
Corporation tax
22,231
-
0
Other taxation and social security
12,661
9,792
Other creditors
3,501
8,497
76,183
46,188
2023-03-312022-04-01false30 October 2023CCH SoftwareCCH Accounts Production 2023.100No description of principal activityMr B MicklerMrs Melanie Mickler036914732022-04-012023-03-31036914732023-03-31036914732022-03-3103691473core:OtherPropertyPlantEquipment2023-03-3103691473core:OtherPropertyPlantEquipment2022-03-3103691473core:CurrentFinancialInstrumentscore:WithinOneYear2023-03-3103691473core:CurrentFinancialInstrumentscore:WithinOneYear2022-03-3103691473core:CurrentFinancialInstruments2023-03-3103691473core:CurrentFinancialInstruments2022-03-3103691473core:ShareCapital2023-03-3103691473core:ShareCapital2022-03-3103691473core:RetainedEarningsAccumulatedLosses2023-03-3103691473core:RetainedEarningsAccumulatedLosses2022-03-3103691473bus:Director12022-04-012023-03-3103691473bus:Director22022-04-012023-03-3103691473core:FurnitureFittings2022-04-012023-03-31036914732021-04-012022-03-3103691473core:OtherPropertyPlantEquipment2022-03-3103691473core:OtherPropertyPlantEquipment2022-04-012023-03-3103691473core:WithinOneYear2023-03-3103691473core:WithinOneYear2022-03-3103691473bus:PrivateLimitedCompanyLtd2022-04-012023-03-3103691473bus:SmallCompaniesRegimeForAccounts2022-04-012023-03-3103691473bus:FRS1022022-04-012023-03-3103691473bus:AuditExemptWithAccountantsReport2022-04-012023-03-3103691473bus:FullAccounts2022-04-012023-03-31xbrli:purexbrli:sharesiso4217:GBP